Tang Capital Management as of Dec. 31, 2020
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 11 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 45.5 | $298M | 16M | 19.20 | |
| Rocket Pharmaceuticals (RCKT) | 24.8 | $163M | 3.0M | 54.84 | |
| Aptevo Therapeutics Com New | 9.8 | $65M | 1.8M | 36.65 | |
| Anaptysbio Inc Common (ANAB) | 8.6 | $57M | 2.6M | 21.50 | |
| La Jolla Pharmaceuticl Com Par | 5.6 | $37M | 9.4M | 3.88 | |
| Coherus Biosciences (CHRS) | 1.7 | $11M | 650k | 17.38 | |
| Vincera Pharma Unit 12/24/2025 | 1.5 | $9.6M | 500k | 19.26 | |
| Relmada Therapeutics (RLMD) | 1.0 | $6.4M | 200k | 32.07 | |
| Bctg Acquisition Corp | 0.8 | $5.4M | 469k | 11.44 | |
| Equillium (EQ) | 0.5 | $3.2M | 600k | 5.35 | |
| Vincera Pharma *w Exp 12/24/202 | 0.2 | $1.1M | 330k | 3.30 |
